INBRAIN Neuroelectronics
PrivateLast Round
Grant
May 6, 2025
Total Funding Raised
$72.22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
INBRAIN Neuroelectronics is a medical technology company that develops graphene-based, AI-powered brain-computer interface (BCI) therapies for neurological conditions such as Parkinson's and epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Medical AI, Sensors, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INBRAIN Neuroelectronics Comparables
Compare INBRAIN Neuroelectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precision Neuroscience | 86% | |
| Axoft | 83% | |
| Neurosoft Bioelectronics | 81% |
INBRAIN Neuroelectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2025 | ||||
| Series B | Oct 29, 2024 | ||||
| Series A | Mar 30, 2021 | ||||
| Seed | Jun 29, 2020 |
Key People
Founding team and executive leadership
INBRAIN Neuroelectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series B, Series A, Seed |
| Alta Life Sciences | Series A, Seed |
| ICF Venture Tech II | Series A |
| Avançsa | Series B |
| Ysios Capital | Seed |
| Fond-ICO Next Tech | Series B |
| imec.xpand | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 232% MoM, reaching 5.4K.
- Jun 4, 2026
4-year collaboration with Merck KGaA to develop peripheral nervous system therapies.
INBRAIN Neuroelectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about INBRAIN Neuroelectronics's valuation, stock price, and market status.
Is INBRAIN Neuroelectronics a public or private company?
INBRAIN Neuroelectronics is a private company.
What is the current stock price of INBRAIN Neuroelectronics?
INBRAIN Neuroelectronics is a private company with no public stock price. No recent secondary market data is available.
How much is INBRAIN Neuroelectronics worth (valuation)?
Valuation information for INBRAIN Neuroelectronics is not publicly available.
Can I buy INBRAIN Neuroelectronics stock?
INBRAIN Neuroelectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was INBRAIN Neuroelectronics's last funding round?
INBRAIN Neuroelectronics's most recent funding round was Grant on May 6, 2025.
Who are the main investors in INBRAIN Neuroelectronics?
Key investors in INBRAIN Neuroelectronics include Asabys Partners, Alta Life Sciences, imec.xpand.
Will INBRAIN Neuroelectronics IPO soon?
No public IPO plans have been announced for INBRAIN Neuroelectronics.
How can I track INBRAIN Neuroelectronics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor INBRAIN Neuroelectronics's secondary market activity and sign up for updates.